A routine blood test that measures a patient’s inflammation levels could improve the early diagnosis and management of a wide range of debilitating autoimmune diseases.
Amylyx readies for make-or-break PhIII, looking to address uncertainty over controversial ALS drug
About a decade ago, David Buseck’s left foot first started dragging during a race. He chalked it up to not being much of a runner.
March 6, 2024